HIGHFDA DRUG

Acella Doxycycline Hyclate 100 mg Recall 2025 for Dissolution Failure - 4,680 Bottles Nationwide

Acella Pharmaceuticals recalls doxycycline hyclate tablets, 100 mg, 500-count bottles distributed nationwide in the USA. Stability testing found the lot did not meet dissolution specifications. Consumers and healthcare providers should stop using the product immediately and contact Acella for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 29, 2025
Status
ACTIVE
Severity
6/10

Quick Facts at a Glance

Recall Date
September 29, 2025
Hazard Level
HIGH
Brands
Doxycycline, Acella Pharmaceuticals
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Doxycycline, Acella Pharmaceuticals
Product type
Doxycycline Hyclate Tablet 100 mg (Rx) 500-count bottle
Model numbers
Lot P24ZLK1, Exp 5/31/2027, NDC 42192-501-05
UPC codes
42192-501, 42192-501-50, 42192-501-05
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 29, 2025

  2. Reported by FDA DRUG

    October 15, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Acella Pharmaceuticals, LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

Doxycycline hyclate is a broad-spectrum antibiotic used to treat infections. The product in question is a 100 mg tablet, distributed nationwide as a prescription medication.

Why This Is Dangerous

The dissolution failure means the drug may not dissolve as expected in the body, potentially reducing efficacy. This can lead to suboptimal treatment outcomes if the patient relies on the tablet for infection control.

Industry Context

This recall is not described as part of a broader industry pattern in the available information.

Real-World Impact

Patients with the affected lot may experience reduced therapeutic effect. The recall emphasizes stopping use and seeking guidance from healthcare providers.

Practical Guidance

How to identify if yours is affected

  1. Check the bottle for NDC 42192-501-05 and Lot P24ZLK1
  2. Verify the Expiry Date 5/31/2027
  3. Confirm quantity is 500 tablets per bottle and 4,680 total bottles recalled

Where to find product info

Refer to the FDA enforcement page for D-0014-2026 and contact Acella Pharmaceuticals for instructions

What timeline to expect

Remedies typically involve replacement or refund as directed by the manufacturer; processing timelines vary by pharmacy and provider

If the manufacturer is unresponsive

  • Document all communications
  • Escalate to consumer protection or FDA recall program if the manufacturer is unresponsive
  • Consider contacting your pharmacist for guidance on alternatives

How to prevent similar issues

  • Always verify the NDC and lot number before taking prescription meds
  • Monitor recall notices from the FDA and manufacturers
  • Choose reputable pharmacies that provide recall updates
  • Ask your pharmacist to confirm product integrity before dispensing medicines

Documentation advice

Keep the recall notice, bottle labels showing NDC and lot, and all correspondence with the manufacturer and healthcare providers

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

NDC 42192-501-05; Lot P24ZLK1; Exp 5/31/2027; Quantity 4,680 bottles; Bottle count 500 per bottle; Distribution Nationwide in the USA; Rx Only; Sold through healthcare providers; Price not disclosed.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Lot P24ZLK1
  • Nationwide distribution in USA

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
6/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot P24ZLK1
Exp 5/31/2027
NDC 42192-501-05
UPC Codes
42192-501
42192-501-50
42192-501-05
Affected States
ALL
Report Date
October 15, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more